Etomoxir (Na salt)
Modify Date: 2024-01-10 16:00:07
Etomoxir (Na salt) structure
|
Common Name | Etomoxir (Na salt) | ||
|---|---|---|---|---|
| CAS Number | 828934-41-4 | Molecular Weight | 320.744 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C15H18ClNaO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Etomoxir (Na salt)(R)-Etomoxir sodium salt is the R-form of Etomoxir sodium salt, acts as an inhibitorof carnitine palmitoyltransferase I (CPT-I), and inhibits palmitate β-oxidation in human, rat and guinea pig. |
| Name | sodium,(2R)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate |
|---|---|
| Synonym | More Synonyms |
| Description | (R)-Etomoxir sodium salt is the R-form of Etomoxir sodium salt, acts as an inhibitorof carnitine palmitoyltransferase I (CPT-I), and inhibits palmitate β-oxidation in human, rat and guinea pig. |
|---|---|
| Related Catalog | |
| Target |
CPT-1[1] |
| In Vitro | (R)-Etomoxir sodium salt is the R-form of Etomoxir sodium salt, acts as an inhibitorof carnitine palmitoyltransferase I (CPT-I), and inhibits palmitate β-oxidation in human, rat and guinea pig[1]. |
| References |
| Molecular Formula | C15H18ClNaO4 |
|---|---|
| Molecular Weight | 320.744 |
| Exact Mass | 320.079132 |
| PSA | 61.89000 |
| LogP | 2.18820 |
| Storage condition | -20℃ |
| Hazard Codes | Xn: Harmful; |
|---|---|
| Risk Phrases | 22 |
| RIDADR | UN 2811 6.1/PG 3 |
| Sodium (2R)-2-[6-(4-chlorophenoxy)hexyl]-2-oxiranecarboxylate |
| 2-Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, sodium salt, (2R)- (1:1) |
| cc-140 |
| (+)-Etomoxir (sodium salt) |
| ANTI-EAPII(TTRAP) |
| (2R)-2-[6-(4-Chlorophenoxy)hexyl]oxiranecarboxylic acid sodium salt |
| MFCD07787411 |
| (+)-Etomoxir sodium salt |
| (R)-(+)-Etomoxir (sodium salt) |